Methylphenidate Hcl Tablets Suppliers & Bulk Manufacturers
Available Forms: Extended-release (ER) tablets
Available Strengths: 18 mg, 27 mg, 36 mg, 54 mg ER tablets
Reference Brands: Concerta
Category: Drugs Using Osmotic Pump Systems
Concerta (methylphenidate) works by blocking reuptake of dopamine and norepinephrine in the brain, increasing their levels to improve attention and focus. It provides sustained, long-lasting symptom control, reducing impulsivity and hyperactivity in ADHD patients, supporting daily functioning and overall quality of life when used as prescribed. Methylphenidate HCl tablets is available in Extended-release (ER) tablets and strengths such as 18 mg, 27 mg, 36 mg, 54 mg ER tablets. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Methylphenidate HCl tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Methylphenidate HCl tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Concerta® (methylphenidate HCl) is regulated in the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP and MDR standards. In the US, FDA approval involved extensive clinical validation, safety assessments, and GMP compliance. In the EU, CE marking certifies conformity with MDR standards. These formulations undergo validation, stability testing, and audits, with comprehensive documentation including safety profiles, clinical data, and manufacturing practices.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Prazosin Hcl Tablets
Strength:
1 mg, 2 mg, 5 mg,10 mg
Form: Extended-release (ER) tablets
Reference Brands: Alpress LP
View DetailsCarbamazepine Tablets
Strength:
200 mg, 300 mg, 400 mg
Form: Extended-release (XR) tablets
Reference Brands: Tegretol XR
View DetailsDoxazosin Mesylate Capsules
Strength:
4 mg, 8 mg, and 12 mg
Form: Extended-release (ER) capsules
Reference Brands: Cardura XL
View DetailsVerapamil Hcl Tablets
Strength:
240 mg once daily
Form: Sustained-release tablets
Reference Brands: Covera-HS®
View DetailsQuick Response Guaranteed | Verified Suppliers